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A B S T R A C T
Introduction. Erection hardness is an elemental component of men’s sexual quality of life that can be easily measured
by the Erection Hardness Score (EHS). However, there are few published data regarding EHS, and there is little
understanding of its relationships to aging, men’s sexual behavior, sexual conﬁdence, and risk factors in Japan.
Aim. To assess EHS and how it correlates to aging, sexual behaviors, sexual self-conﬁdence, and risk factors in a
Japanese population database.
Methods. A web-based cross-sectional nationwide survey conducted between March and May 2009 in Japan.
Main Outcome Measures. EHS, lifestyle factors, comorbidities, general health, sexual conﬁdence, frequency of
sexual behaviors, and attitudes toward treatment of erectile dysfunction (ED).
Results. A total of 7,710 men with a mean age of 39.3 ± 13.0 years participated in this survey. In 6,528 participants
who were not using phosphodiesterase type 5 inhibitors, 3,540 (54.2%) had EHS ≤ 3 and 1,196 (18.3%) had
EHS ≤ 2. We found a signiﬁcant age-dependent decrease in EHS, sexual conﬁdence, and frequency of sexual
activities. Sexual conﬁdence was strongly associated with higher EHS but was also associated with older age groups,
presence of offspring, awareness of better general health, and greater frequency of sexual activity. In age-adjusted
multivariate logistic regression, risk factors for a lower EHS (deﬁned as EHS ≤ 2) were heavy smoking, which was
deﬁned as more than two packs per day (odds ratio [OR], 1.7) or a history of metabolic syndrome (OR, 1.4),
hypertension (OR, 1.2), and diabetes mellitus (OR, 1.4).
Conclusions. EHS correlates to various elements, such as aging, sexual behaviors, sexual conﬁdence, and ED-related
risk factors, and can be a valuable tool in clinical practice for monitoring and treating ED and thereby improving the
quality of life for men and their sexual partners. Kimura M, Shimura S, Tai T, Kobayashi H, Baba S, Kano M,
and Nagao K. A web-based survey of Erection Hardness Score and its relationship to aging, sexual behavior,
confidence, and risk factors in Japan. Sex Med 2013;1:76–86.
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Introduction
I t has been more than 20 years since theNational Institutes of Health Consensus Panel
declared that erectile dysfunction (ED) is an
important public health issue [1]. The panel
emphasized the importance of understanding its
etiology, risk factors, pathophysiology, diagnostic
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assessment, and treatments and the need for
further assessment regarding the diversity of ED
across geographic, racial, ethnic, socioeconomic,
and cultural groups [1]. In this context, several
researchers have investigated erectile function,
focusing on aforementioned topics using several
validated objective measures, such as the Interna-
tional Index Erectile Function (IIEF) [2], Sexual
Health Inventory for Men, Sexual Encounter
Proﬁle [3], and the Self-Esteem And Relationship
Questionnaire (SEAR) [4].
Satisfaction with erection hardness initiates a
cascade of psychosocial beneﬁts, such as higher
self-conﬁdence and self-esteem, which ultimately
lead to overall sexual satisfaction for men and
their partners [5]. With the aim of measuring
erection hardness as a targeted goal of ED
therapy, the Erection Hardness Score (EHS) was
developed by Goldstein et al. in the sildenaﬁl
clinical trial program [6]. The EHS is a robust,
single-item, self-reported tool that scores erec-
tion hardness on a four-point scale and can be
used in daily clinical practice [5]. Recently, psy-
chometric analysis supported the use of EHS as a
simple, reliable, and valid tool for the assessment
of erection hardness in the research setting [7],
but there are few studies using the EHS in a
population-based sample.
Aims
It has been reported that ED is associated
with aging, unhealthy lifestyle choices, and
comorbidities as well as psychological elements,
including low self-esteem, low sexual conﬁdence,
depression, anxiety, and relationship problems
[8–13]. These ﬁndings suggest that ED is a major
factor associated with men’s physical and mental
health. However, there have been no published
data from Japan in terms of an investigation of
EHS and its relationship with the aforemen-
tioned factors. The aim of the present study is
to provide updated information about the rela-
tionship between EHS and aging, sexual behav-
ior, sexual conﬁdence, and risk factors using
a web-based, nationwide, Japanese population
database.
Methods
Study Population
A web-based cross-sectional nationwide study
was conducted in Japan between March 19 and
May 31, 2009. Regarding the enrollment of this
study, we recruited the participants through a
special website entitled “Hardness of Erected
Penis is Pride of Men” in conjunction with a
campaign for the 10th anniversary of the intro-
duction of sildenaﬁl to the Japanese market. The
targeted population of this survey was nonspeciﬁc
Japanese male citizens older than 20 years.
Because these ﬁndings were to be based on an
observational web-based survey, we did not set
strict exclusion criteria, except for age. They pro-
vided informed consent and voluntarily reported
their private information. There was no compen-
sation for participants in this study. The survey
included questions regarding demographics,
lifestyles, comorbidities, self-reported conﬁ-
dence for general and sexual health, EHS, sub-
jective assessment of erectile function, sexual
behaviors, attitudes toward ED treatment, and
phosphodiesterase type 5 (PDE5) inhibitor use
(Appendix 1).
Erection hardness was assessed using the EHS
in the provided questionnaire (question 10).
Brieﬂy, EHS1 indicates erection hardness at
sexual stimulation as larger but not hard, EHS2
indicates hard but not hard enough for penetra-
tion, EHS3 indicates hard enough for penetra-
tion but not completely hard, and EHS4
indicates completely hard and fully rigid [14]. In
the present study, translation and linguistic vali-
dation of the Japanese version of EHS were con-
ducted according to accepted methods (forward
translation, back translation, and cognitive
debrieﬁng) [15]. First, two translators indepen-
dently reviewed the EHS questionnaire as trans-
lated by a Japanese consultant and modiﬁed the
translation on the basis of cultural differences.
Subsequently, a draft of the Japanese version of
EHS was produced. Then, cognitive debrieﬁng
was performed with ﬁve patients with ED, and
the appropriateness of expressions and word use
were assessed as well as whether questionnaire
items were important, meaningful, and generally
acceptable. The ﬁnal decision was made based on
discussion in an international harmonization
meeting evaluating the ﬁrst and second versions
and back translation to conﬁrm conceptual
equivalence during the process of translation and
linguistic validation [16].
Main Outcome Measures
The main outcome measures for this study were
the EHS, lifestyle factors, comorbidities, general
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health, sexual conﬁdence, frequency of sexual
behaviors, and attitudes toward treatment of
ED.
Statistical Analysis
To determine the association among EHS, aging,
and sexual behaviors, the Spearman Rank Test was
applied to calculate the Spearman rho (r). To
determine predictive factors for sexual conﬁdence,
we conducted multivariate logistic regression
analysis in 7,710 participants. In this model,
explanatory variables were age groups (range 1–6),
presence of offspring (yes vs. no), self-reported
awareness of better health (range 1–5), alcohol
consumption (range 1–4), smoking status (range
1–4), history of metabolic syndrome (yes vs. no),
medical history of comorbidities including hyper-
tension, dyslipidemia, and diabetes mellitus (yes
vs. no), self-reported conﬁdence in erectile func-
tion (yes vs. no), EHS (range 1–4), frequency of
sexual intercourse (range 1–6), frequency of mas-
turbation (range 1–6), experience with failure of
sexual intercourse in past year (yes vs. no), aware-
ness of ED in lifetime (yes vs. no), inclination to
visit a clinic for ED treatment (yes vs. no), and
PDE5 inhibitor use (yes vs. no). Additionally, to
determine predictive factors for a lower EHS
(EHS ≤ 2), multivariate logistic regression analy-
ses were employed among 6,528 participants not
using PDE5 inhibitors. In this analysis, age
groups, lifestyle factors (e.g., alcohol consumption
and smoking status), history of metabolic syn-
drome, and comorbidities (e.g., hypertension,
dyslipidemia, and diabetes) were assigned as
explanatory variables. Statistical signiﬁcance was
deﬁned as P < 0.05. All statistical analyses were
performed with STATA software version 11.2
(Stata Corporation, College Station, TX, USA).
Descriptive data are reported as mean ± standard
deviation or number (percentage) unless otherwise
speciﬁed.
Results
Characteristics of the Participants
A total of 7,710 men with a mean age of 39.3 ± 13.0
(ranged from 20 to 89) years participated in this
survey. The demographics and clinical characteris-
tics are summarized in Table 1. More than half
4,454 (57.8%) were married, and 3,750 (48.6%)
had offspring. In terms of lifestyle factors, 2,714
(35.2%) drank alcohol every day and 4,997 (64.8%)
were nonsmokers. Twenty-four percent had been
diagnosed with metabolic syndrome. Regarding
comorbidities, 1,538 (20%), 2,003 (26%), and 581
(7.5%) had a history of hypertension, dyslipidemia,
and diabetes, respectively. Comparing participants
not using PDE5 inhibitors (n = 6,528) with those
using PDE5 inhibitors, nonusers were more likely
to be younger (37.9 ± 12.5 vs. 46.6 ± 13.1 years)
and have a lower rate of alcohol consumption and
cigarette smoking and were less likely to have
history of metabolic syndrome, hypertension,
dyslipidemia, and diabetes (all P < 0.001).
EHS
Among the 6,528 participants who did not use
PDE5 inhibitors, the number of participants with
EHS1, EHS2, EHS3, and EHS4 was 431 (6.6%),
765 (11.7%), 2,344 (35.9%), and 2,988 (45.8%),
respectively. Furthermore, 3,540 (54.2%) partici-
pants had EHS ≤ 3 and 1,196 (18.3%) participants
had EHS ≤ 2. Stratifying EHS by age group
showed that EHS decreased with increasing age,
which was found to be statistically signiﬁcant by
the Spearman rank correlation (r = −0.32,
P < 0.001; Figure 1).
Sexual Behaviors
Frequency of sexual activity in 7,710 participants is
summarized in Figure 2. With respect to fre-
Table 1 Characteristics of the 7,710 participants
Number of
Participants, %
Marital status
Married 4,454 (57.8)
Unmarried 3,256 (42.2)
Age, year
20–29 1,935 (25.1)
30–39 2,304 (29.9)
40–49 1,798 (23.3)
50–59 966 (12.5)
60–69 539 (7.0)
≥70 168 (2.2)
Presence of offspring 3,750 (48.6)
Alcohol consumption
None 1,888 (24.5)
2–3 times in a month 1,455 (18.9)
1–2 times in a week 1,653 (21.4)
Every day 2,714 (35.2)
Smoking status
Nonsmoker 4,997 (64.8)
A few cigarettes per day 781 (10.1)
One pack per day 1,662 (21.6)
More than 2 packs per day 270 (3.5)
Metabolic syndrome 1,867 (24.2)
History of comorbidities
Hypertension 1,538 (20.0)
Dyslipidemia 2,003 (26.0)
Diabetes mellitus 581 (7.5)
78 Kimura et al.
Sex Med 2013;1:76–86 © 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
quency of sexual intercourse, 28% of participants
answered “no intercourse within past half-year”
whereas 59% had intercourse at least once per
month. Regarding frequency of masturbation,
7.6% participants answered “no masturbation
within the past half-year,” and 88% masturbated at
least once per month, a higher frequency com-
pared with that of sexual intercourse.
There was no association between frequency of
sexual intercourse and aging (r = −0.01, P = 0.587;
Figure 2A). On the contrary, we found a signiﬁ-
cant decreased frequency of masturbation with
increased age (r = −0.49, P < 0.001; Figure 2B).
Among 7,710 participants, a signiﬁcant positive
association was found between EHS and frequency
of sexual intercourse (r = 0.17, P < 0.001). Simi-
larly, there was signiﬁcant positive association
between EHS and frequency of masturbation
(r = 0.30, P < 0.001).
Frequency of sexual activity stratiﬁed with
PDE5 inhibitors use in 7,710 participants is sum-
marized in Figure 3. A use of PDE5 inhibitors was
signiﬁcantly increased by age (r = 0.24, P < 0.001;
Figure 3A), whereas frequency of sexual inter-
course was statistically higher in PDE5 inhibitor
user than nonuser (P < 0.001; Figure 3B).
Confidence in Sexual Ability
Of the 7,710 men who participated in the present
web-based survey, 3,172 (41.4%) reported conﬁ-
dence in their sexual ability, and 4,538 (58.6%)
reported they were not conﬁdent. Just as EHS
decreased with increased age, there was apparent
association between a decrease in men’s sexual
conﬁdence and older age, which was statistically
signiﬁcant (chi-square test, P = 0.001; Figure 4).
Results of multivariate logistic regression for
men’s sexual conﬁdence are listed in Table 2. In
this analysis, higher EHS (odds ratio [OR], 3.36;
P < 0.001) was identiﬁed as having strong associa-
tion with conﬁdence in sexual ability. We also
found several signiﬁcant predictive factors, such as
age 60 to 69 years (OR, 1.58; P = 0.002), presence
of offspring (OR, 1.22; P = 0.003), awareness of
better health (OR, 1.24; P < 0.001), higher fre-
quency of sexual intercourse (OR, 1.45; P < 0.001),
and masturbation (OR, 1.06; P = 0.002). Con-
versely, marital status, lifestyle factors (e.g., ciga-
rette smoking, drinking alcohol), metabolic
syndrome, and comorbidities did not correlate
with sexual conﬁdence.
Factors Associated with Lower Erectile
Hardness Score
Prevalence of low EHS was signiﬁcantly higher
among participants who were heavy smokers and
had metabolic syndrome as well as those with a
history of hypertension, dyslipidemia, or diabetes
(chi-square test, all P < 0.001). Using a multivari-
ate logistic regression model, we examined plau-
sible factors associated with lower EHS (deﬁned as
EHS ≤ 2) among 6,528 participants who were not
using PDE5 inhibitors (Table 3). The factor most
strongly associated with lower EHS was older age,
which demonstrated a 16-fold increased likelihood
of lower EHS in the oldest (>70 years) compared
with the youngest (20–29 years) group. Apart
from aging effects, smoker had a 1.1-fold increased
odds of low EHS compared with nonsmokers.
If smoking status were analyzed as a categorical
Figure 1 Erection Hardness Score
(EHS) in various age groups among
6,528 participants who were not using
phosphodiesterase type 5 (PDE5)
inhibitors.
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AB
Figure 2 Relationships between aging and sexual behaviors in 7,710 participants. (A) Frequency of sexual intercourse
stratified by age categories. (B) Frequency of masturbation stratified by age categories.
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variable, men who smoke more than two packs per
day had a 1.7-fold increased likelihood of low EHS
compared with nonsmokers. However, those who
drank alcohol did not show a signiﬁcant associa-
tion with lower EHS compared with nonalcohol
drinkers. In terms of comorbidities, men who had
metabolic syndrome demonstrated a 1.4-fold
increased likelihood of lower EHS than men who
did not. Similarly, history of hypertension and dia-
betes mellitus increased the likelihood of lower
EHS by 1.2- and 1.4-fold, respectively, when com-
pared with men with no history of these
comorbidities. In contrast, history of dyslipidemia
was not associated with increased likelihood of
lower EHS (OR, 1.07; P = 0.368).
Discussion
In this study, we utilized EHS instead of using the
IIEF or the Quality of Erection Questionnaire
because EHS is simple measure that can be easily
used in routine clinical practice, both as a screen-
ing tool and a monitoring tool, as well as in clinical
trial research as a validated outcome measure [7].
To the best of our knowledge, this is the ﬁrst study
to investigate EHS in a Japanese cohort as well as
A
B
Figure 3 (A) A percentage of PDE5
inhibitors use based on age catego-
ries. (B) A percentage of frequency of
sexual intercourse based on use of
PDE5 inhibitors.
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the ﬁrst study to elucidate the association between
EHS and several factors, including sexual conﬁ-
dence, sexual behaviors, and risk factors. Previous
studies investigating the prevalence of ED have
reported varying rates, such as 19–36% in the
United States [17,18], 32% in France, 32% in
Korea, and 45% in the Middle East [19]. With
regard to studies in Japan, previously reported
prevalence of ED was inconsistent, ranging from
36% to 89% [20–22]. This large difference is likely
explained by differences in the deﬁnition of ED,
methodology, and small sizes of study population.
In this study, we analyzed data from 6,528 partici-
pants and found that 54% and 18% of surveyed
Japanese men had EHS ≤ 3 and EHS ≤ 2, respec-
tively. This is in contrast to an EHS ≤ 3 rate of
26% reported as a result of a telephone survey
conducted in Taiwan. The lower rate in the
Taiwan study could easily be due to increased
embarrassment of participants in the phone inter-
view versus an Internet survey [19].
We found that more than half of adults aged
≥65 years were sexually active (deﬁned as inter-
course more than once per month), although the
aged population of this survey might have rela-
tively speciﬁc characteristics. In previous studies,
Japanese men were considered to be less sexually
active and to have less interest in their sexual func-
Figure 4 Relationship between men’s
confidence in sexual ability and aging.
Table 2 Multivariate logistic regression analysis for
men’s confidence in sexual ability*
Covariates Odds ratio 95% CI P value
Age, y
20–29 Reference — —
30–39 0.96 0.83–1.12 0.624
40–49 0.99 0.82–1.17 0.873
50–59 1.12 0.88–1.40 0.331
60–69 1.58 1.18–2.12 0.002
≥70 1.08 0.66–1.75 0.766
Presence of offspring 1.22 1.07–1.40 0.003
Awareness of better health 1.24 1.17–1.32 <0.001
Alcohol consumption 1.03 0.98–1.08 0.220
Smoking 1.02 0.96–108 0.610
Metabolic syndrome 1.07 0.93–1.23 0.367
Hypertension 1.00 0.86–1.16 0.997
Hyperlipidemia 0.95 0.83–1.09 0.466
Diabetes mellitus 1.05 0.84–1.32 0.650
Erection Hardness Score 3.35 3.09–3.65 <0.001
Frequency of sexual intercourse 1.45 1.40–1.50 <0.001
Frequency of masturbation 1.06 1.02–1.11 0.002
*Analysis was conducted in 7,710 participants.
CI = confidence interval
Table 3 Multivariate logistic regression analysis
predicting factors associated with EHS ≤ 2*
Covariates Odds ratio 95% CI P value
Age, year
20–29 Reference — —
30–39 1.35 1.10–1.67 0.005
40–49 1.95 1.56–2.43 <0.001
50–59 4.70 3.71–5.95 <0.001
60–69 10.6 8.04–14.0 <0.001
≥70 16.2 10.6–24.6 <0.001
Alcohol consumption 0.97 0.92–1.03 0.301
Cigarette smoking 1.14 1.06–1.22 <0.001
Metabolic syndrome 1.41 1.20–1.67 <0.001
History of comorbidities
Hypertension 1.21 1.03–1.43 0.023
Dyslipidemia 1.07 0.92–1.26 0.368
Diabetes mellitus 1.38 1.09–1.74 0.008
*Analysis was conducted in 6,528 men who were not using phosphodiesterase
type 5 inhibitors.
EHS = Erection Hardness Score; CI = confidence interval
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tion compared with men in Western countries
[23,24]. However, our results show a discrepancy
with this previous understanding. Japanese cul-
tural attitudes toward sexuality may have become
more liberal in recent decades, perhaps as a result
of inﬂuence from other countries. Another plau-
sible reason could be the difference of rate of
PDE5 inhibitor users between current and previ-
ous cohorts. In present-day Japan, PDE5 inhibi-
tors are widely distributed and available at many
clinics, which may enhance the sexual ability and
activity in older Japanese men. However, regard-
ing treatment for ED among older adults, sexual
problems are infrequently discussed with physi-
cians even in the United States [25]. A previous
study in two communities showed that there is a
greater decline in sexual activity in Japanese men
compared with American men, especially in older
age groups [23]. However, this could mean that
older Japanese men might be more likely to seek
treatment for ED, which may reduce the gap of
sexual function between Japan and Western coun-
tries in this subset of age groups.
One important ﬁnding from the present study is
that men who have higher EHS are more likely to
have higher frequency of sexual activities and
higher sexual conﬁdence. Similarly, previous
studies from Western countries reported that erec-
tion hardness was directly associated with im-
provement in outcomes, including intercourse
enjoyment, sexual satisfaction (i.e., frequency of
satisfactory intercourse and satisfactionwith sex life
and sexual relationship), emotional well-being (i.e.,
self-esteem, personal relationships, conﬁdence in
erectile function, and conﬁdence overall) and satis-
faction with their ED treatment [5,26–30].
Although causality is difﬁcult to determine, an
implication from our result could be that men who
improve their erection hardness through medical
intervention, such as use of PDE5 inhibitors, are
more likely to become sexually active and conﬁdent
than men without treatment. Therefore, some
effort is warranted in Japan to educate middle-aged
and older adults in their sexuality; encouraging
communication between physician and patient
about sex is essential to maintain or improve sexual
health. We expect that the use of EHS in clinical
practice could aid this communication.
We found that participants who had higher
EHS demonstrated a 3.4-fold increased likelihood
of sexual conﬁdence, suggesting that erectile func-
tion is a strong predictor for conﬁdence in sexual
ability. Previous observations showing an associa-
tion between ED and depression may further
support our ﬁndings, given that depression is
known to cause low self-esteem/conﬁdence
[31,32]. Numerous studies demonstrated that
PDE5 inhibitors can improve erectile function in
men with ED and are well-tolerated treatments,
even in older men [6,33,34]. We found that older
men who used PDE5 inhibitors had a higher EHS
than men in the same age group who did not,
suggesting that the use of PDE5 inhibitors might
have resulted in enhancing their sexual conﬁdence.
In the present study, we identiﬁed factors that
contribute to lower EHS, some of which have not
been reported previously in a Japanese population.
Because the EHS has a strong convergent relation-
ship with the IIEF Erectile Function (EF) domain
[7,35], we assumed that the EHS might correlate
with ED risk factors. In addition, EHS is focused
only on physiologic factors (i.e., hardness of erect
penis), which can represent real physiologic erec-
tile function if the individual’s perception is accu-
rate. In this age-adjusted, multivariate, logistic
regression analysis, we deﬁned lower EHS as
EHS ≤ 2 (i.e., men who responded that their erec-
tion is “larger, but not hard” or “hard, but not hard
enough for penetration”), representing men with
moderate to severe ED by IIEF EF domain evalu-
ation based on the aforementioned studies [7,35].
A similar study from Taiwan analyzing EHS in
1,060 men deﬁned ED as EHS ≤ 3 (i.e., all men
who did not respond “completely hard and fully
rigid”) [36], which corresponds to mild to severe
ED on the IIEF EF domain.
As we expected, aging contributes most strongly
to the decline of EHS in multivariate logistic
regression analysis (Table 3), which was also
reported in several previously published studies
[22,23,37]. Examination of the impact of lifestyle
factors (e.g., alcohol consumption, cigarette
smoking) and metabolic syndrome to EHS has
been limited in the Asian population. In present
study, we found that cigarette smoking was a sig-
niﬁcant predictive factor for lower EHS/ED using
Japanese population data, but that alcohol con-
sumption had no association, which is consistent
with previous reports from Western countries [38–
42]. Regarding metabolic syndrome, we found that
it too was a signiﬁcant predictive factor for
EHS ≤ 2. However, two previous studies exploring
the association between obesity and ED in Japan
[21,37] showed that obesity was not identiﬁed
as a risk factor for ED. This discrepancy might
be attributed to a relatively small sample size
owing to a lower incidence of obesity in Japanese
men, resulting in insufﬁcient statistical power.
A Web-Based Survey of Erection Hardness Score in Japan 83
Sex Med 2013;1:76–86© 2013 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
Comorbidities as risk factors for EDhave beenwell
researched in many countries. Hypertension
and diabetes were strongly associated with lower
EHS, which is consistent with previous reports
from Western countries as well as from Japan
[20,22,43,44]. In contrast, dyslipidemia was not
associated with lower EHS in our study, which
contradicts some reports from Western countries
[45,46], but is consistent with all previous reports
from Japan [20,22,37].
There are several limitations in our study. First,
this web-based survey data might have sampling
biases because of the nature of web-based cross-
sectional data acquisition. Individuals who
responded to this survey might be more interested
in Japanese sexual function and behavior than those
who did not volunteer for this survey. In addition,
participants may be younger in this study than
other studies because the participants needed to be
familiar with current communication technology
to access the Internet [20]. By the same token, older
participants who have these skills may be more
intellectually and sexually active than those of the
same age groupwhodonot. Second, the conﬁdence
measure on this study is not based on a psycho-
metrically validated measure, such as the SEAR
questionnaire, which could weaken present results.
Third, the survey did not ask for information
regarding drug use. Because some cases of ED
could be a side effect of speciﬁcmedications, such as
beta-blockers, we cannot determine causality of
ED inmenwho have comorbidities. Finally, certain
participants perhaps could not realize their
comorbidity proﬁles if these are subclinical, which
can bias the analyzed results.
Despite these limitations, the present study, to
the best of our knowledge, is the largest online
survey to evaluate erection hardness using the vali-
dated EHS in Asia. This study has updated the
knowledge base regarding epidemiology for ED,
sexual behaviors, and risk factors in the Japanese
population. These results revealed that erection
hardness was strongly associated with age, sexual
activity, conﬁdence in sexual ability, and risk
factors.
Conclusion
We found that there is a signiﬁcant correlation
among older age, a decrease in EHS, conﬁdence in
sexual ability, and frequency of sexual activities. In
a risk factor analysis, we found that older age (i.e.,
>70 years [OR, 16.2]) and heavy smoking (OR,
1.7) as well as a history of metabolic syndrome
(OR, 1.4), hypertension (OR, 1.2), and diabetes
mellitus (OR, 1.4) were signiﬁcant predictive
factors for ED in this Japanese population. When
men, regardless of age, encounter problems with
erectile function, a conversation about sexual
health between physician and patient might be
necessary to improve erectile function, which
could consequently lead to a better quality of life.
Our ﬁndings may help encourage men to be aware
of their sexual health and seek proper treatment
options for ED. The EHS may be useful in aiding
the interaction between physician and patient.
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Appendix 1: Questionnaire Survey
1. Are you married?
a. Married
b. Unmarried
2. How old are you?
3. Do you have children?
a. Yes
b. No
4. What is your current general health?
a. Excellent
b. Very good
c. Good
d. Fair
e. Poor
5. Do you have a habit of drinking?
a. None
b. 2–3 times a month
c. 1–2 times a week
d. Every day
6. Do you smoke?
a. None
b. A few cigarettes per day
c. One pack per day
d. More than two packs per day
7. Have you ever been diagnosed as having metabolic syndrome?
a. Yes
b. No
8. Have you ever been diagnosed as having
a. hypertension
b. dyslipidemia
c. diabetes
d. No
9. Are you conﬁdent in your erection hardness?
a. Yes
b. No
10. Which is most frequent condition of your penis during sexual
activity?
a. Larger, but no hard
b. Hard, but not hard enough for penetration
c. Hard enough for penetration, but not completely hard
d. Completely hard and fully rigid
11. How often do you have sexual intercourse?
a. More than once per 3 days
b. Once per week
c. 2–3 times per month
d. Once per month
e. A few times per half year
f. No intercourse within past half year
12. How often do you masturbate?
a. More than once per 3 days
b. Once per week
c. 2–3 times per month
d. Once per month
e. A few times per half year
f. No masturbation within past half year
13. Do you have experience that you fail to sexual intercourse due
to insufﬁciency of erection during past year?
a. Yes
b. No
14. Do you have conﬁdence in your sexual ability to satisfy your
partner?
a. Yes
b. No
15. Have you ever been aware that you have erectile dysfunction?
a. Yes
b. No
16. Do you want to visit a clinic if your erectile function were
decreased?
a. Yes
b. No
17. Have you used pills for erectile dysfunction such as Viagra,
Levitra, Cialis during past year?
a. Yes
b. No
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